Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.
about
Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune responsePhase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancerOncology.Antineoplastic agents and the associated myelosuppressive effects: a review.A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study GroupPharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy.Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer.5-Fluorouracil derivatives: a patent review.Progress report. Cytotoxic therapy for gastrointestinal carcinoma.Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patientsIncorporation of intermediary products of 5-FU anabolism into colorectal cancerBioavailability and feasibility of subcutaneous 5-fluorouracil.Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.Mature results from three large controlled studies with raltitrexed ('Tomudex').Thymosin α1 as a stimulatory agent of innate cell-mediated immune response.Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells.Re-evaluation of cellular radiosensitization by 5-fluorouracil: high-dose, pulsed administration is effective and preferable to conventional low-dose, chronic administration.Mitomycin C, 5-fluorouracil and radiation in advanced, locally recurrent rectal cancer.Protective effects of water-soluble low-molecular-weight beta-(1,3-1,6)d-glucan purified from Aureobasidium pullulans GM-NH-1A1 against UFT toxicity in mice.Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions.Prolonged infusion of fluorinated pyrimidines in gastrointestinal malignancies: a review of recent clinical trials.Infusional cancer chemotherapy: historical evolution and future development at the Cancer Center of Boston.Antineoplastic drug resistance and breast cancer.Treatment of advanced colorectal cancer with recombinant interferon alpha and fluorouracil: activity in liver metastasis.Biomodulation of Fluorouracil in colorectal cancer.Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.Letter: Blood levels of 5-fluorouracil during intravenous infusion.Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluorouracil for inoperable head and neck cancer.Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck.Chemotherapy, immunotherapy and chemoimmunotherapy of colorectal cancer.Evaluation of the performance of elastomeric pumps in practice: are we under-delivering on chemotherapy treatments?Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.
P2860
Q21263126-589B75D4-199D-4CD2-9024-B1E78476974AQ24810562-58E3EE57-3614-42F4-8CE2-C66A377F1C00Q28361226-4369B496-D56D-4BFF-868E-D5CED939289BQ30493410-22A280AD-2865-4A36-99C1-1C69B2BF35FAQ33417225-B9BE9BF9-FC64-457C-A7D1-1EB8E06838CAQ33495664-27DC51D9-492A-442E-8DC5-F758A20D9137Q33581242-6A1058F9-7FA2-4E44-BCEC-F995826CDB98Q33750445-5BD4DC9A-941E-40F1-9E32-1F80CF69D02FQ33884698-F8879DA5-275B-4157-902E-1F14D8085E9CQ34253978-CFADEE38-D474-4CAB-A824-6476B2CB47F3Q34471867-85973082-84A4-4413-94FC-EFD4640D4788Q34517614-F7826A4F-836A-478F-B45B-8B28F252B574Q34528490-4DFEF3F9-58B8-4AB5-9D4D-0DF5C6010F19Q35976676-111B9AE3-D3A8-4383-B120-F41D530BE18DQ35993608-4779F504-3C08-4DF4-BD53-731A312615B7Q35993743-A59384F0-0DD3-4FCA-A140-EAC92230A8D3Q36042825-7458B446-0996-4D1B-8846-DB09F31E7061Q36079774-A4BFB4AB-7347-4B9E-B1E4-DFDD9905B985Q36081891-286A9330-ECD9-41A2-A9B0-BA02AE1E4B45Q36141244-072F10C1-5E6B-4907-9CEF-09A150F327DCQ36291303-5CDC3730-12A8-4D55-8F69-6722BCBA301EQ38050836-6ACBD3B6-0AD8-4DC5-9913-1BBC80348F89Q38166233-F1D0AE4E-89E9-47E5-9AF3-4C2ECD6A62FBQ39053456-AED65095-8DF4-484D-8925-4C6A6A827AE9Q39162488-D7E8F027-1CF6-4CA9-98B7-47D145897DFBQ39503957-9CA55FAC-E65D-4669-86AB-C79A085B3A4BQ39841359-04E68BCF-482A-482E-B73A-752BD4951523Q40284011-CC883AD9-EB02-4B76-8FDB-319C41D17FE3Q40387127-229FD0B9-BE67-4E60-BF49-B4E7535DDCDFQ40603529-E15CA68E-E7E3-4A60-BC15-FC4710EFC7B3Q40619705-0F58DB6A-76A8-4E52-8494-30F4F3824D1DQ40738870-002D8F0C-5FCC-432F-B0CD-79603B204957Q40859206-FF0D1711-45E4-4FF7-80F7-75DE77D2282BQ41134747-CB626933-C9BC-4D08-AA8D-7B6DF9C7CE3FQ41978204-1AE03EF1-853D-4689-A08D-20AB2B6DCCF2Q43626543-0354C7B4-404D-4A87-B246-574C7522B0F4Q43971994-992EB062-5D21-4A08-8FAF-CE297B3A295BQ44221353-96E0B6CB-6AA6-4D74-8002-14B8CC44E349Q47735139-B13366FA-202D-4627-A102-3DB85316A8F7Q54077157-E2259879-0B19-4FA0-8FB4-7D5DAA73D601
P2860
Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.
description
1975 nî lūn-bûn
@nan
1975 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@ast
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@en
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@nl
type
label
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@ast
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@en
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@nl
prefLabel
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@ast
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@en
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@nl
P2093
P1433
P1476
Comparison of continuously inf ...... ith colorectal adenocarcinoma.
@en
P2093
Vaitkevicius VK
P304
P356
10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C
P407
P577
1975-07-01T00:00:00Z